| Haber: |
Haber Kaynağı: Çeşitli Haber Siteleri
STAT+: Pharmalittle: Activist investor targets Cardinal Health; 340B drug sales rose to $44 billion last year
Elliott Management, the activist investor, has a large position in Cardinal Health and is seeking a handful of seats on the board.
https://www.statnews.com/pharmalot/2022/08/16/covid19-vaccines-novavax-cardinal-340b-merck-emergent-gilead/?utm_campaign=rss
|
